• FR

IFCT-0802

Publications:
  • Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: Results from the IFCT-0802 trial
  • Randomized Phase II-III Study of Bevacizumab in Combination with Chemotherapy in Previously Untreated Extensive Small-Cell Lung Cancer: Results from the IFCT-0802 Trial
  • Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et al
  • Synopsis: IFCT-0802_Synopsis_211209.pdf

    Intergroupe Francophone de Cancérologie Thoracique

    Siège social
    10 rue de la Grange-Batelière
    75009 PARIS

    Standard : 01.56.81.10.45
    Recherche Clinique : 01.56.81.10.46

    Informations

    • Mentions légales
    • Avertissement
    • Plan du site

    Suivez-nous

    • Twitter
    • LinkedIn
    © IFCT 2021 - IFCT_TOUS_DROITS_RESERVES
    Contact Devenir membre Espace membre E-lettre Deconnexion